Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison King

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Annals of Emergency Medicine|September 15, 2020
A Survey-Based Needs Assessment of Barriers to Optimal Sickle Cell Disease Care in the Emergency DepartmentElizabeth A Linton, Dania A Goodin, Jane S Hankins, et al.
Blood Advances|September 17, 2020
Intentional and unintentional nonadherence to hydroxyurea among people with sickle cell disease: a qualitative studyJason R Hodges, Shannon M Phillips, Sarah Norell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 8, 2019
Late Morbidity and Mortality Among Medulloblastoma Survivors Diagnosed Across Three Decades: A Report From the Childhood Cancer Survivor StudyRalph Salloum, Yan Chen, Yutaka Yasui, et al.
Blood Advances|May 30, 2024
Impact of an individualized pain plan to treat sickle cell disease vaso-occlusive episodes in the emergency departmentLauren Siewny, Allison King, Cathy L Melvin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2018
Late Effects Screening Guidelines after Hematopoietic Cell Transplantation (HCT) for Hemoglobinopathy: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCTShalini Shenoy, Javid Gaziev, Emanuele Angelucci, et al.
British Journal of Haematology|November 16, 2022
Characterising the prevalence of overweight and obese status among adults with sickle cell diseaseStephanie O Ibemere, Charity I Oyedeji, Liliana Preiss, et al.
American Journal of Hematology|September 12, 2018
The sickle cell disease implementation consortium: Translating evidence-based guidelines into practice for sickle cell diseaseLisa D DiMartino, Ana A Baumann, Lewis L Hsu, et al.
Neuro-Oncology|October 11, 2017
Longitudinal assessment of late-onset neurologic conditions in survivors of childhood central nervous system tumors: a Childhood Cancer Survivor Study reportElizabeth M Wells, Nicole J Ullrich, Kristy Seidel, et al.
Blood Advances|August 14, 2020
Building access to care in adult sickle cell disease: defining models of care, essential components, and economic aspectsJulie Kanter, Wally R Smith, Payal C Desai, et al.
Pediatric Blood & Cancer|April 23, 2014
Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromasBrigitte C Widemann, Dusica Babovic-Vuksanovic, Eva Dombi, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Annals of Emergency Medicine|September 15, 2020
A Survey-Based Needs Assessment of Barriers to Optimal Sickle Cell Disease Care in the Emergency DepartmentElizabeth A Linton, Dania A Goodin, Jane S Hankins, et al.
Blood Advances|September 17, 2020
Intentional and unintentional nonadherence to hydroxyurea among people with sickle cell disease: a qualitative studyJason R Hodges, Shannon M Phillips, Sarah Norell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 8, 2019
Late Morbidity and Mortality Among Medulloblastoma Survivors Diagnosed Across Three Decades: A Report From the Childhood Cancer Survivor StudyRalph Salloum, Yan Chen, Yutaka Yasui, et al.
Blood Advances|May 30, 2024
Impact of an individualized pain plan to treat sickle cell disease vaso-occlusive episodes in the emergency departmentLauren Siewny, Allison King, Cathy L Melvin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2018
Late Effects Screening Guidelines after Hematopoietic Cell Transplantation (HCT) for Hemoglobinopathy: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCTShalini Shenoy, Javid Gaziev, Emanuele Angelucci, et al.
British Journal of Haematology|November 16, 2022
Characterising the prevalence of overweight and obese status among adults with sickle cell diseaseStephanie O Ibemere, Charity I Oyedeji, Liliana Preiss, et al.
American Journal of Hematology|September 12, 2018
The sickle cell disease implementation consortium: Translating evidence-based guidelines into practice for sickle cell diseaseLisa D DiMartino, Ana A Baumann, Lewis L Hsu, et al.
Neuro-Oncology|October 11, 2017
Longitudinal assessment of late-onset neurologic conditions in survivors of childhood central nervous system tumors: a Childhood Cancer Survivor Study reportElizabeth M Wells, Nicole J Ullrich, Kristy Seidel, et al.
Blood Advances|August 14, 2020
Building access to care in adult sickle cell disease: defining models of care, essential components, and economic aspectsJulie Kanter, Wally R Smith, Payal C Desai, et al.
Pediatric Blood & Cancer|April 23, 2014
Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromasBrigitte C Widemann, Dusica Babovic-Vuksanovic, Eva Dombi, et al.
Pageof 6